ReShape Lifesciences Inc reports results for the quarter ended in June - Earnings Summary

Vyome Holdings

08/08/2023 24:05

* ReShape Lifesciences Inc  RSLS.OQ  reported a quarterly
adjusted
loss of $1.08​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of $1.79
per share.
    * Revenue fell 22.1% to $2.25 million from a year ago;
analysts
expected $2.61 million. 
    * ReShape Lifesciences Inc's reported EPS for the quarter
was a
loss of $1.08​.
    * The mean earnings estimate of analysts had fallen by
about 10.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * ReShape Lifesciences Inc shares had fallen by 2.0% this
quarter and lost 78.5% so far this year.
    * The company reported a quarterly loss of $3.49 million.
    * Wall Street's median 12-month price target for ReShape
Lifesciences Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 11:05 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.79          -1.08          Beat
 Mar. 31 2023      -4.21          -1.56          Beat
 Dec. 31 2022      -10.00         -8.59          Beat
 Sep. 30 2022      -17.75         -26.00         Missed